These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 18055997

  • 1. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels.
    Lijfering WM, Veeger NJ, Brouwer JL, van der Meer J.
    Haematologica; 2007 Dec; 92(12):1703-6. PubMed ID: 18055997
    [Abstract] [Full Text] [Related]

  • 2. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.
    Lijfering WM, Coppens M, van de Poel MH, Middeldorp S, Hamulyák K, Bank I, Veeger NJ, Prins MH, Büller HR, van der Meer J.
    Thromb Haemost; 2007 Aug; 98(2):457-63. PubMed ID: 17721631
    [Abstract] [Full Text] [Related]

  • 3. Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels.
    Lijfering WM, Coppens M, Veeger NJ, Middeldorp S, Hamulyák K, Prins MH, Büller HR, van der Meer J.
    Thromb Res; 2008 Aug; 123(2):244-50. PubMed ID: 18279917
    [No Abstract] [Full Text] [Related]

  • 4. Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
    Folkeringa N, Coppens M, Veeger NJ, Bom VJ, Middeldorp S, Hamulyak K, Prins MH, Büller HR, van der Meer J.
    Thromb Haemost; 2008 Jul; 100(1):38-44. PubMed ID: 18612536
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [A new thrombophilia risk factor: the increase of plasma factor VIII].
    Hernández-Jerónimo J, Pérez-Campos E, Matadamas C, Majluf-Cruz A.
    Rev Invest Clin; 2003 Jul; 55(4):448-57. PubMed ID: 14635611
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.
    Thromb Res; 2008 Jul; 121(6):743-50. PubMed ID: 17804043
    [Abstract] [Full Text] [Related]

  • 9. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism.
    O'Donnell J, Laffan M.
    Clin Lab; 2001 Jul; 47(1-2):1-6. PubMed ID: 11214218
    [Abstract] [Full Text] [Related]

  • 10. Venous thrombosis, oral contraceptives and high factor VIII levels.
    Bloemenkamp KW, Helmerhorst FM, Rosendaal FR, Vandenbroucke JP.
    Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758
    [Abstract] [Full Text] [Related]

  • 11. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
    Kamphuisen PW, Eikenboom JC, Vos HL, Pablo R, Sturk A, Bertina RM, Rosendaal FR.
    Thromb Haemost; 1999 May; 81(5):680-3. PubMed ID: 10365736
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Factor VIII activity in patients with central retinal vein occlusion in comparison to patients with a history of pelvic and lower limb venous thrombosis and a healthy control group].
    Faude F, Faude S, Siegemund A, Wiedemann P.
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):862-6. PubMed ID: 15499522
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, Todoli J, Simó M, Corella D, Ricart JM.
    Clin Hemorheol Microcirc; 2008 Oct; 40(2):79-87. PubMed ID: 19029633
    [Abstract] [Full Text] [Related]

  • 17. Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic syndrome: results of a multicenter study.
    Kreuz W, Stoll M, Junker R, Heinecke A, Schobess R, Kurnik K, Kelsch R, Nowak-Göttl U.
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1901-6. PubMed ID: 16709943
    [Abstract] [Full Text] [Related]

  • 18. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.
    Keijzer MB, Borm GF, Blom HJ, Bos GM, Rosendaal FR, den Heijer M.
    Thromb Haemost; 2007 Jan; 97(1):32-7. PubMed ID: 17200768
    [Abstract] [Full Text] [Related]

  • 19. The role of cysteine and homocysteine in venous and arterial thrombotic disease.
    Marcucci R, Brunelli T, Giusti B, Fedi S, Pepe G, Poli D, Prisco D, Abbate R, Gensini GF.
    Am J Clin Pathol; 2001 Jul; 116(1):56-60. PubMed ID: 11447752
    [Abstract] [Full Text] [Related]

  • 20. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O, Dávid M, Habon T, Nagy A, Keszthelyi Z, Kovács N, Losonczy H.
    Orv Hetil; 2005 Oct 09; 146(41):2121-5. PubMed ID: 16304806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.